Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Dual Tumor Microenvironment Remodeling by Glucose-Contained Radical Copolymer for MRI-Guided Photoimmunotherapy
Hongwei Cheng et al.
ADVANCED MATERIALS (2022)
The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
Zhixian Wu et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2022)
Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease
Jie Luo et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation
Qi Zhang et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)
Concordance between hepatic biopsy and the APRI index (Ast to Platelet Ratio Index) for the diagnosis of cirrhosis in patients with autoimmune liver disease
Carmen Yanette Suarez-Quintero et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2021)
Engineering nanotheranostic strategies for liver cancer
Lei Cao et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis
Asmaa M. Zahran et al.
ACTA ONCOLOGICA (2020)
Prognostic Value of Prealbumin in Liver Cancer: A Systematic Review and Meta-Analysis
Weizhou Qiao et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2020)
Differential Expression and Diagnostic Significance of Pre-Albumin, Fibrinogen Combined with D-Dimer in AFP-Negative Hepatocellular Carcinoma
Wei Jing et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma
Zhaobo Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
Lei Cao et al.
AGING-US (2020)
Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma
Li Huang et al.
CANCER CELL INTERNATIONAL (2020)
Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma A meta-analysis
Ping Fang et al.
MEDICINE (2020)
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
Di-Yang Xie et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Serum AFU, GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value
Genqiang Gong et al.
CELLULAR AND MOLECULAR BIOLOGY (2020)
The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma
Li-xiang Zhang et al.
BMC CANCER (2019)
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
Xueping Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Rule of changes in serum GGT levels and GGT/ALT and AST/ALT ratios in primary hepatic carcinoma patients with different AFP levels
Jian-Gong Yang et al.
CANCER BIOMARKERS (2018)
D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer
Akira Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma
Shanshan Chen et al.
HEPATOLOGY RESEARCH (2017)
Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
Xin Guo et al.
ONCOTARGET (2017)
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
Dou-Sheng Bai et al.
SCIENTIFIC REPORTS (2017)
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis
Brian I. Carr et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
Eric Waidely et al.
ANALYST (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study
Jun Ji et al.
PLOS ONE (2016)
Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China
Song-Lin An et al.
Asian Pacific Journal of Cancer Prevention (2015)
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma
Zhiguo Zhang et al.
ONCOTARGETS AND THERAPY (2015)
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
Li-Li Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
Jong Young Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL
Hidenori Toyoda et al.
CANCER SCIENCE (2011)
Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation
Min-Jie Ju et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?
F Farinati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Share Paper
